Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Boston Scientific (BSX)
NYSE:BSX
Boston Scientific (BSX) Stock Price & Analysis
2,354 Followers
BSX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$48.35 - $69.21
Previous Close$68.99
Volume8.17M
Average Volume (3M)6.35M
Market Cap
$101.41B
Enterprise Value$109.89B
Total Cash (Recent Filing)$865.00M
Total Debt (Recent Filing)$9.10B
Price to Earnings (P/E)64.5
Beta0.81
Next Earnings
Jul 24, 2024EPS Estimate
$0.58Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.07
Shares Outstanding1,467,095,627
10 Day Avg. Volume7,461,324
30 Day Avg. Volume6,345,795
Standard Deviation0.06
R-Squared0.41
Alpha0.00259
Financial Highlights & Ratios
Price to Book (P/B)-91.35
Price to Sales (P/S)28.72
Price to Cash Flow (P/CF)26.40
P/FCF Ratio33.60
Enterprise Value/Market CapN/A
Enterprise Value/Revenue7.72
Enterprise Value/Gross Profit11.11
Enterprise Value/Ebitda31.83
Forecast
1Y Price Target
$80.33Price Target Upside9.65% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering22
Boston Scientific News
Bulls Say, Bears Say
Bulls Say
Financial Guidance And Analyst SentimentManagement's increased full-year organic growth guidance indicates sustained momentum in procedure volumes.
Product Adoption And Market PerformanceEarly adoption of Farapulse technology in the US is robust, suggesting strong future performance.
Product Launch And Market GrowthContinued strong growth is expected to be driven by the ~90 new products BSX launched.
Bears Say
Regulatory SetbacksAcurate TAVR no longer anticipates FDA approval for 2024, which is a slight disappointment and an extended timeline for potential approval.
Slowing GrowthOrganic revenue growth slowed slightly to 13.1% in 1Q24 from 13.6% in 4Q23.
Valuation ConcernsDespite bullish growth, the current stock valuation is well above historical multiples, implying that growth expectations may already be priced in.
---
Ownership Overview
4.90% Insiders
30.53% Mutual Funds
19.27% Other Institutional Investors
45.30% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
BSX FAQ
What was Boston Scientific’s price range in the past 12 months?
Boston Scientific lowest stock price was $48.35 and its highest was $69.21 in the past 12 months.
What is Boston Scientific’s market cap?
Currently, no data Available
When is Boston Scientific’s upcoming earnings report date?
Boston Scientific’s upcoming earnings report date is Jul 24, 2024 which is in 89 days.
How were Boston Scientific’s earnings last quarter?
Boston Scientific released its earnings results on Apr 24, 2024. The company reported $0.56 earnings per share for the quarter, beating the consensus estimate of $0.514 by $0.046.
Is Boston Scientific overvalued?
According to Wall Street analysts Boston Scientific’s price is currently Undervalued.
Does Boston Scientific pay dividends?
Boston Scientific does not currently pay dividends.
What is Boston Scientific’s EPS estimate?
Boston Scientific’s EPS estimate is $0.58.
How many shares outstanding does Boston Scientific have?
Boston Scientific has 1,469,895,400 shares outstanding.
What happened to Boston Scientific’s price movement after its last earnings report?
Boston Scientific reported an EPS of $0.56 in its last earnings report, beating expectations of $0.514. Following the earnings report the stock price went up 5.682%.
Which hedge fund is a major shareholder of Boston Scientific?
Among the largest hedge funds holding Boston Scientific’s share is PRIMECAP Management Co. It holds Boston Scientific’s shares valued at 2B.
---
Boston Scientific Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$80.33 (9.65% Upside)
$80.33 (9.65% Upside)
Blogger Sentiment
Bullish
BSX Sentiment 60%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 3.4M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $455.2K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▲ 0.8%
Last 30 Days ▼ 4.0%
Last 30 Days ▼ 4.0%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
42.01%
12-Months-Change
Fundamentals
Return on Equity
8.64%
Trailing 12-Months
Asset Growth
8.21%
Trailing 12-Months
Company Description
Boston Scientific
Boston Scientific Corporation engages in the manufacturing of medical devices and products that are used in various interventional medical specialties worldwide. The company provides implantable devices including heart monitors, technologies for treating coronary artery disease and other cardiovascular disorders, and devices for diagnosing and treating gastrointestinal and pulmonary problems.
---
BSX Company Deck
---
BSX Earnings Call
Q1 2024
0:00 / 0:00
---
BSX Revenue Breakdown
61.93% Cardiovascular
38.08% MedSurg
---
BSX Stock 12 Months Forecast
Average Price Target
$80.33
▲(9.65% Upside)
Technical Analysis
Best Analysts Covering BSX
1 Year
1 Year Success Rate
21/23 ratings generated profit
1 Year Average Return
+23.90%
reiterated a buy rating 2 days ago
Copying Michael Matson's trades and holding each position for 1 Year would result in 91.30% of your transactions generating a profit, with an average return of +23.90% per trade.
---